GAL and ovarian carcinoma: Modifications of LacNAc by sialic acid and Gal decorations on α4β1 or α5β1 negatively affect cell–cell and cell–matrix interactions, thereby increasing cancer cell mobility in colon adenocarcinoma, ovarian cancer, and hepatocellular carcinoma37,64–69.